These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12001059)

  • 21. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008.
    von Gottberg A; Cohen C; de Gouveia L; Meiring S; Quan V; Whitelaw A; Crowther-Gibson P; Madhi SA; Whitney CG; Klugman KP
    Vaccine; 2013 Aug; 31(38):4200-8. PubMed ID: 23684826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
    Abzug MJ; Pelton SI; Song LY; Fenton T; Levin MJ; Nachman SA; Borkowsky W; Rosenblatt HM; Marcinak JF; Dieudonne A; Abrams EJ; Pathak I;
    Pediatr Infect Dis J; 2006 Oct; 25(10):920-9. PubMed ID: 17006288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients.
    Ranieri R; Veronelli A; Santambrogio C; Pontiroli AE
    AIDS Res Hum Retroviruses; 2005 May; 21(5):407-9. PubMed ID: 15929703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine.
    Miiro G; Kayhty H; Watera C; Tolmie H; Whitworth JA; Gilks CF; French N
    J Infect Dis; 2005 Nov; 192(10):1801-5. PubMed ID: 16235180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Will the 7-valent pneumococcal vaccine have a similar impact on all invasive pneumococcal infections in children in Germany as in the Kaiser Permanente Trial?
    von Kries R; Hermann M; Al-Lahham A; Siedler A; Reinert RR
    Eur J Pediatr; 2002 Dec; 161 Suppl 2():S140-3. PubMed ID: 12494261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.
    Lexau CA; Lynfield R; Danila R; Pilishvili T; Facklam R; Farley MM; Harrison LH; Schaffner W; Reingold A; Bennett NM; Hadler J; Cieslak PR; Whitney CG;
    JAMA; 2005 Oct; 294(16):2043-51. PubMed ID: 16249418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV+ patients.
    Sanz JC; Cercenado E; Marín M; Ramos B; Ardanuy C; Rodríguez-Avial I; Bouza E
    Clin Microbiol Infect; 2011 Jul; 17(7):1094-8. PubMed ID: 21463396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospitalizations for invasive pneumococcal disease among human immunodeficiency virus-1 infected children, adolescents and young adults in the United States in the era of highly active antiretroviral therapy and the conjugate pneumococcal vaccine.
    Kourtis AP; Ellington S; Bansil P; Jamieson DJ; Posner SF
    Pediatr Infect Dis J; 2010 Jun; 29(6):561-3. PubMed ID: 20094005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive pneumococcal disease in Australia, 2004.
    Roche PW; Krause VL; Bartlett M; Coleman D; Cook H; Davis C; Fielding JE; Holland R; Giele C; Gilmour R; Kampen R; Brown M; Gilbert L; Hogg G; Murphy D;
    Commun Dis Intell Q Rep; 2006; 30(1):80-92. PubMed ID: 16637236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deteriorating pneumococcal-specific B-cell memory in minimally symptomatic African children with HIV infection.
    Iwajomo OH; Finn A; Moons P; Nkhata R; Sepako E; Ogunniyi AD; Williams NA; Heyderman RS
    J Infect Dis; 2011 Aug; 204(4):534-43. PubMed ID: 21791655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil.
    Ho YL; Brandão AP; de Cunto Brandileone MC; Lopes MH
    Vaccine; 2013 Aug; 31(37):4047-53. PubMed ID: 23684823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection.
    Tarragó D; Casal J; Ruiz-Contreras J; Ramos JT; Rojo P; Snippe H; Jansen WT;
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):165-70. PubMed ID: 15643002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003.
    Adegbola RA; Hill PC; Secka O; Ikumapayi UN; Lahai G; Greenwood BM; Corrah T
    Trop Med Int Health; 2006 Jul; 11(7):1128-35. PubMed ID: 16827713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination.
    Dworkin MS; Ward JW; Hanson DL; Jones JL; Kaplan JE;
    Clin Infect Dis; 2001 Mar; 32(5):794-800. PubMed ID: 11229848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent pneumococcal bacteremia: risk factors and outcomes.
    Turett GS; Blum S; Telzak EE
    Arch Intern Med; 2001 Sep; 161(17):2141-4. PubMed ID: 11570945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive pneumococcal disease in the Kimberley, 1995-2001.
    Mak DB
    Aust J Rural Health; 2004 Dec; 12(6):237-40. PubMed ID: 15615574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009.
    Yin Z; Rice BD; Waight P; Miller E; George R; Brown AE; Smith RD; Slack M; Delpech VC
    AIDS; 2012 Jan; 26(1):87-94. PubMed ID: 22008657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.